phenylalanyl-phenylalanyl-arginine chloromethyl ketone has been researched along with thromboplastin in 13 studies
| Studies (phenylalanyl-phenylalanyl-arginine chloromethyl ketone) | Trials (phenylalanyl-phenylalanyl-arginine chloromethyl ketone) | Recent Studies (post-2010) (phenylalanyl-phenylalanyl-arginine chloromethyl ketone) | Studies (thromboplastin) | Trials (thromboplastin) | Recent Studies (post-2010) (thromboplastin) |
|---|---|---|---|---|---|
| 26 | 0 | 2 | 10,540 | 281 | 2,126 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guha, A; Konigsberg, WH; Laue, TM; Lin, TC; Nemerson, Y; Ross, JB; Thiruvikraman, SV; Waxman, E | 1 |
| Jesty, J; Lorenz, A; Rodriguez, J; Wun, TC | 1 |
| Ezban, M; Freskgârd, PO; Kjalke, M; Persson, E; Rao, LV; Sorensen, BB; Williams, T | 1 |
| Ezban, M; Hedner, U; Hoffman, M; Kjalke, M; Monroe, DM; Oliver, JA; Roberts, HR | 2 |
| St Charles, R; Tulinsky, A; Zhang, E | 1 |
| Botticella, F; Buono, C; Chiariello, M; Cirillo, P; Condorelli, M; Ezban, M; Golino, P; Guarino, A; Lambiase, C; Piro, O; Ragni, M; Ravera, A; Scognamiglio, A | 1 |
| Freskgård, PO; Nielsen, LS; Olsen, OH; Persson, E; Petersen, LC | 1 |
| Ezban, M; Heldin, CH; Johnell, M; Rönnstrand, L; Rorsman, C; Siegbahn, A | 1 |
| Carlsson, K; Carlsson, U; Freskgård, PO; Lindgren, M; Osterlund, M; Owenius, R; Persson, E; Svensson, M | 1 |
| Petersen, LC | 1 |
| Liotta, DC; Lu, YJ; Shoji, M; Snyder, JP; Sun, A | 1 |
| Brat, DJ; El-Rayes, BF; Kisiel, W; Liotta, DC; Lu, YJ; Moore, TW; Ndungu, JM; Parker, ET; Petersen, LC; Sarkaria, JN; Shoji, M; Snyder, JP; Sun, A; Zhu, S | 1 |
2 review(s) available for phenylalanyl-phenylalanyl-arginine chloromethyl ketone and thromboplastin
| Article | Year |
|---|---|
The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulation.
Topics: Amino Acid Chloromethyl Ketones; Blood Coagulation; Factor VIIa; Humans; Models, Biological; Monocytes; Platelet Activation; Serine Proteinase Inhibitors; Thromboplastin | 1998 |
Active site-inhibited seven: mechanism of action including signal transduction.
Topics: Amino Acid Chloromethyl Ketones; Binding Sites; Factor VIIa; Gene Expression Regulation; Humans; Serine Proteinase Inhibitors; Signal Transduction; Thromboplastin | 2001 |
11 other study(ies) available for phenylalanyl-phenylalanyl-arginine chloromethyl ketone and thromboplastin
| Article | Year |
|---|---|
Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex.
Topics: Amino Acid Chloromethyl Ketones; Binding Sites; Dansyl Compounds; Factor VIIa; Fluorescence Polarization; Liposomes; Phosphatidylcholines; Solubility; Structure-Activity Relationship; Thromboplastin; Ultracentrifugation | 1992 |
Initiation of the tissue factor pathway of coagulation in the presence of heparin: control by antithrombin III and tissue factor pathway inhibitor.
Topics: Amino Acid Chloromethyl Ketones; Amino Acid Sequence; Antithrombin III; Blood Coagulation; Chromogenic Compounds; Dansyl Compounds; Enzyme Activation; Factor VIIa; Factor X; Heparin; Humans; Lipoproteins; Recombinant Proteins; Thromboplastin | 1996 |
Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor.
Topics: Amino Acid Chloromethyl Ketones; Binding Sites; Binding, Competitive; Cell Line; Cell Membrane; Circular Dichroism; Factor VIIa; Fibrin; Humans; Kinetics; Protein Conformation; Recombinant Proteins; Thromboplastin; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1997 |
The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration.
Topics: Adult; Amino Acid Chloromethyl Ketones; Aspirin; Binding Sites; Binding, Competitive; Blood Coagulation; Blood Platelets; Calcium; Cells, Cultured; Cyclooxygenase Inhibitors; Drug Administration Schedule; Drug Interactions; Factor VII; Factor VIIa; Fibrinolytic Agents; Humans; Kinetics; Lipopolysaccharides; Monocytes; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Binding; Recombinant Proteins; Serine Proteinase Inhibitors; Thrombin; Thromboplastin | 1997 |
Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
Topics: Amino Acid Chloromethyl Ketones; Amino Acid Sequence; Aprotinin; Catalytic Domain; Crystallography, X-Ray; Epidermal Growth Factor; Factor IXa; Factor VIIa; Models, Molecular; Molecular Sequence Data; Mutation; Protein Conformation; Sequence Homology, Amino Acid; Serine Proteinase Inhibitors; Thromboplastin | 1999 |
Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits.
Topics: Amino Acid Chloromethyl Ketones; Animals; Binding Sites; Blood Coagulation; Blood Platelets; Coronary Circulation; Factor VIIa; Fibrinogen; Hemodynamics; Hemostatics; Humans; Myocardial Infarction; Myocardial Reperfusion Injury; Rabbits; Recombinant Proteins; Thromboplastin | 2000 |
Binding of Zn2+ to a Ca2+ loop allosterically attenuates the activity of factor VIIa and reduces its affinity for tissue factor.
Topics: Alanine; Allosteric Site; Amino Acid Chloromethyl Ketones; Binding Sites; Calcium; Catalytic Domain; Dose-Response Relationship, Drug; Factor VIIa; Histidine; Humans; Ions; Kinetics; Models, Molecular; Protein Binding; Protein Conformation; Protein Structure, Tertiary; Recombinant Proteins; Surface Plasmon Resonance; Thromboplastin; Time Factors; Zinc | 2000 |
Binding of factor VIIa to tissue factor on human fibroblasts leads to activation of phospholipase C and enhanced PDGF-BB-stimulated chemotaxis.
Topics: Amino Acid Chloromethyl Ketones; Becaplermin; Binding Sites; Cells, Cultured; Chemotaxis; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Activation; Factor VIIa; Factor Xa; Fibroblasts; Humans; Isoenzymes; Muscle, Smooth, Vascular; Phospholipase C gamma; Phosphorylation; Platelet-Derived Growth Factor; Protein Binding; Proto-Oncogene Proteins c-sis; Serine Proteinase Inhibitors; Signal Transduction; Thrombin; Thromboplastin; Type C Phospholipases | 2000 |
Probing inhibitor-induced conformational changes along the interface between tissue factor and factor VIIa.
Topics: Amino Acid Chloromethyl Ketones; Anticoagulants; Binding Sites; Electron Spin Resonance Spectroscopy; Factor VIIa; Fluorescent Dyes; Mutagenesis, Site-Directed; Naphthalenesulfonates; Protein Binding; Protein Conformation; Serine Proteinase Inhibitors; Solubility; Spectrometry, Fluorescence; Spin Labels; Sulfhydryl Reagents; Thromboplastin | 2001 |
Synthesis of EF24-tripeptide chloromethyl ketone: a novel curcumin-related anticancer drug delivery system.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Curcumin; Drug Delivery Systems; Drug Screening Assays, Antitumor; Factor VIIa; Humans; Models, Molecular; Oxidation-Reduction; Thromboplastin | 2006 |
Visualizing cancer and response to therapy in vivo using Cy5.5-labeled factor VIIa and anti-tissue factor antibody.
Topics: Amino Acid Chloromethyl Ketones; Animals; Carbocyanines; Cells, Cultured; Factor VIIa; Heterografts; Humans; Mice; Neoplasms; Optical Imaging; Paclitaxel; Thromboplastin | 2015 |